These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 18952470)
41. Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast. Gonzalez LO; Corte MD; Vazquez J; Junquera S; Sanchez R; Viña A; Rodriguez JC; Lamelas ML; Vizoso F Histopathology; 2008 Oct; 53(4):403-15. PubMed ID: 18983606 [TBL] [Abstract][Full Text] [Related]
42. Expression of matrix metalloproteinases and their inhibitors at the feto-maternal interface in unruptured ectopic tubal pregnancy. Qiu X; Xie Y; Chen L; Gemzell-Danielsson K Acta Obstet Gynecol Scand; 2011 Sep; 90(9):966-71. PubMed ID: 21644936 [TBL] [Abstract][Full Text] [Related]
43. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes. He S; Prasanna G; Yorio T Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3737-45. PubMed ID: 17652746 [TBL] [Abstract][Full Text] [Related]
45. The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis. Matsuno K; Adachi Y; Yamamoto H; Goto A; Arimura Y; Endo T; Itoh F; Imai K J Gastroenterol; 2003; 38(4):348-54. PubMed ID: 12743774 [TBL] [Abstract][Full Text] [Related]
46. Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration. Leu ST; Batni S; Radeke MJ; Johnson LV; Anderson DH; Clegg DO Exp Eye Res; 2002 Jan; 74(1):141-54. PubMed ID: 11878827 [TBL] [Abstract][Full Text] [Related]
47. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats]. Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283 [TBL] [Abstract][Full Text] [Related]
48. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology. Lesauskaite V; Epistolato MC; Castagnini M; Urbonavicius S; Tanganelli P Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871 [TBL] [Abstract][Full Text] [Related]
49. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. Soini Y; Satta J; Määttä M; Autio-Harmainen H J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152 [TBL] [Abstract][Full Text] [Related]
50. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Di Girolamo N; McCluskey P; Lloyd A; Coroneo MT; Wakefield D Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):671-9. PubMed ID: 10711680 [TBL] [Abstract][Full Text] [Related]
51. Significance of cell-surface expression of matrix metalloproteinases and their inhibitors on gastric epithelium and infiltrating mucosal lymphocytes in progression of Helicobacter pylori-associated gastritis. Koyama S Scand J Gastroenterol; 2004 Nov; 39(11):1046-53. PubMed ID: 15545160 [TBL] [Abstract][Full Text] [Related]
52. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus. Hu J; Zhang X; Nothnick WB; Spencer TE Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428 [TBL] [Abstract][Full Text] [Related]
53. mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue. Lichtinghagen R; Musholt PB; Stephan C; Lein M; Kristiansen G; Hauptmann S; Rudolph B; Schnorr D; Loening SA; Jung K Anticancer Res; 2003; 23(3B):2617-24. PubMed ID: 12894549 [TBL] [Abstract][Full Text] [Related]
54. Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease. Moesgaard SG; Aupperle H; Rajamäki MM; Falk T; Rasmussen CE; Zois NE; Olsen LH Res Vet Sci; 2014 Dec; 97(3):560-7. PubMed ID: 25458505 [TBL] [Abstract][Full Text] [Related]
55. Expression of matrix metalloproteinases, their inhibitors, and lysyl oxidase in myocardial samples from dogs with end-stage systemic and cardiac diseases. Fonfara S; Hetzel U; Tew SR; Cripps P; Dukes-McEwan J; Clegg PD Am J Vet Res; 2013 Feb; 74(2):216-23. PubMed ID: 23363345 [TBL] [Abstract][Full Text] [Related]
56. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study. Mroczko B; Groblewska M; Barcikowska M J Alzheimers Dis; 2013; 37(2):273-83. PubMed ID: 23792694 [TBL] [Abstract][Full Text] [Related]
57. Role of matrix metalloproteinases in renal pathophysiologies. Catania JM; Chen G; Parrish AR Am J Physiol Renal Physiol; 2007 Mar; 292(3):F905-11. PubMed ID: 17190907 [TBL] [Abstract][Full Text] [Related]
58. Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans. Aupperle H; Disatian S J Vet Cardiol; 2012 Mar; 14(1):59-71. PubMed ID: 22364722 [TBL] [Abstract][Full Text] [Related]
59. Immunohistochemistry of MMPs and TIMPs. Okada Y Methods Mol Biol; 2010; 622():211-9. PubMed ID: 20135284 [TBL] [Abstract][Full Text] [Related]
60. Effects of choline treatment in concentrations of serum matrix metalloproteinases (MMPs), MMP tissue inhibitors (TIMPs) and immunoglobulins in an experimental model of canine sepsis. Kocaturk M; Eralp-Inan O; Tvarijonaviciute A; Cansev M; Ozyigit MO; Ceron JJ; Yilmaz Z; Kahraman MM Vet Immunol Immunopathol; 2016 Nov; 180():9-14. PubMed ID: 27692098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]